NOTES
TO THE NOVARTIS GROUP CONSOLIDATED FINANCIAL STATEMENTS
183
NOTES
TO THE RESTATED CONSOLIDATED BALANCE SHEET
32.9.
USD
1 636 million reduction of pension assets by actuarial differences recognized
in equity less USD 346 million of related deferred tax.
32.10.
Consolidation of the employee
share participation foundation reduces cash, short-term deposits and marketable
securities.
32.11.
Other
current assets increase due to the consolidation of the employee share participation
foundation.
32.12.
Reduction
in equity from consolidation of employee share participation foundation, including
liabilities for cashsettled plans; reduction due to elimination of previously
recognized
actuarial differences relating to pension and other post-employment benefit plans,
net of tax and increase due to minority interests no longer shown as a separate
line but which are now included as a separate component in equity.
32.13.
Minority
interests now included as a separate component in total equity.
32.14.
USD 898 million recording of actuarial liabilities
relating to pension and other post-employment benefit plans, USD 153 million of
net liabilities for cash-settled employee plans and consolidation of the employee
share participation foundation less USD 426 million of related deferred taxes.
NOTES
TO THE RESTATED CONSOLIDATED CASH FLOW STATEMENT
32.15.
Consolidation
of the employee share participation foundation with resulting operating cash outflow
mainly related to the cash settled portion of share-based compensation.
32.16.
A total USD 127 million reduction in cash out-flow from
financing activities arising from a USD 72 million dividend
paid by Novartis AG to the now consolidated employee
share participation foundation and USD 55 million from
sale of Novartis AG shares by the employee share participation
foundation.
